HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced delayed graft function (DGF) after cadaveric kidney transplantation (CKT) with selective OKT3 induction and aggressive intraoperative management.

AuthorsR J Taylor, R J Stratta, B H Zorn, A N Langnas, B W Shaw Jr
JournalTransplantation proceedings (Transplant Proc) Vol. 23 Issue 5 Pg. 2317-8 (Oct 1991) ISSN: 0041-1345 [Print] United States
PMID1926370 (Publication Type: Journal Article)
Chemical References
  • Muromonab-CD3
Topics
  • Adult
  • Cadaver
  • Child
  • Humans
  • Immunosuppression Therapy (methods)
  • Kidney
  • Kidney Transplantation (methods, physiology)
  • Muromonab-CD3 (therapeutic use)
  • Organ Preservation
  • Retrospective Studies
  • Tissue and Organ Procurement

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: